Investigator-initiated randomized controlled trials in children with epilepsy: Mission impossible?

Epilepsia Open
Amerins WeijenbergLEV‐VPA Study Group

Abstract

In children many antiepileptic drugs (AEDs) are prescribed off-label due to a lack of well-designed randomized controlled trials (RCTs). We conducted a multicenter RCT in the Netherlands to compare levetiracetam and valproic acid as monotherapy in children with newly diagnosed epilepsy. After 2 years, we had to stop this investigator-initiated trial prematurely because the inclusion rate was too low. We analyzed the reasons for this failure, assessed the various issues involved in performing RCTs in children, and now give recommendations for future studies. A questionnaire was completed by all investigators involved in the study. It included questions about the motivation to participate and the perceived reasons for recruitment failure. We also studied literature about financial, logistic, legal, and ethical aspects of RCTs in children. Main reasons for recruitment failure were overestimation of the number of eligible AED-naive children referred by general pediatricians; personal preferences of investigators for specific antiepileptic drugs; and the extensive administrative load due to extra regulations and guidelines for children. Fundraising for investigator-initiated trials is difficult and the majority of RCTs concerning AE...Continue Reading

References

Nov 9, 2002·Epilepsia·Irene A W KotsopoulosJ André Knottnerus
Dec 4, 2002·The Journal of Pediatrics·Patrina H Y CaldwellJonathan C Craig
May 21, 2003·The Journal of Pediatrics·Patrina H y CaldwellJonathan C Craig
Apr 10, 2004·Journal of Child Neurology·James W WhelessUNKNOWN EPMN-105 Study Group
Sep 1, 2004·Lancet·Patrina H Y CaldwellJonathan C Craig
Jul 2, 2008·Paediatric Drugs·Allison M Chung, Lea S Eiland
Sep 10, 2008·Epilepsy Research·Gregory L HolmesJohn Messenheimer
Oct 20, 2009·Lancet·Terry P KlassenMartin Offringa
Mar 5, 2010·The New England Journal of Medicine·Tracy A GlauserUNKNOWN Childhood Absence Epilepsy Study Group
Jun 2, 2010·Current Pharmaceutical Design·A D HenschelJ Boos
Nov 30, 2011·Archives of Disease in Childhood·Nicolino RupertoAgnès Saint Raymond
Apr 30, 2013·Handbook of Clinical Neurology·Jean-Paul AmannCatherine Chiron
May 7, 2013·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Ingo BorggraefeUNKNOWN German HEAD Study Group
Nov 26, 2014·Paediatric Drugs·Tom Leibson, Gideon Koren
May 28, 2015·CNS Drugs·Amerins WeijenbergPetra M C Callenbach
May 27, 2016·Archives of Disease in Childhood·Pirkko LepolaSaskia de Wildt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.